Ashkelon buying Cannabis

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Ashkelon buying Cannabis

Recent regulatory reforms approved by the Israeli Ministry of Health i allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patients ii in the wake of recent events, particularly the opening of the war in Gaza. This surge has resulted in more than 2, new patients in just one month, approaching the peak numbers of and bringing the total number to over , as of November As part of the new plan of work, the software development phase will focus on innovative elements in the field of artificial intelligence that will increase their data collection and analysis. Physicians licensed to prescribe medical cannabis and Israeli Ministry of Health authorities have reported a notable surge in demand after the recent conflict. There is a burgeoning presence of initiatives by both corporate entities and private individuals aimed at providing cannabis to individuals residing in the southern region. The increasing trend comes after a period of data stagnation in the first half of the year. The Israeli medical community is experiencing a tremendous increase in the number of patients seeking treatment for post-trauma, marking a significant shift from the previous decline in this category. This license allows BYND Cannasoft to trade in medical cannabis products through an agreement with a licensed cannabis grower in Israel. In Israel, the cannabis and pharmaceuticals industries are part of the critical infrastructure sector, and I am very proud of how the team is coming together to work through this horrific situation,' said Yftah Ben Yaackov, CEO and Director of BYND Cannasoft. We are grateful to be in this position to help our country and its people. Many of the medical cannabis patients receiving new licenses are war casualties, as doctors began issuing licenses for post-trauma to victims of the recent events. In terms of patient age, more than 60, medical cannabis patients in Israel, nearly half of the total, fall in the age range. The second-largest group comprises approximately 44, patients aged , with the remaining 24, patients aged 66 and over. There is also a smaller percentage of patients up to the age of 20, particularly children with conditions like autism or epilepsy. The data also indicate an increase in patients using relatively high doses, with 29, patients holding a license for 40 grams of cannabis per month, 27, patients for 50 grams, and 25, patients for 20 grams. Additionally, 20, patients have licenses for 30 grams, 13, for 60 grams, and about 15, patients for 70 grams per month or more. BYND Cannasoft owns and markets 'Benefit CRM,' a proprietary customer relationship management CRM software product enabling small and medium-sized businesses to optimize their day-to-day business activities such as sales management, personnel management, marketing, call center activities, and asset management. This device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues. The EZ-G device includes technological advancements as a sex toy with a more realistic experience, and the prototype utilizes sensors to determine what enhances the users' pleasure. The user can control the device through a Bluetooth app installed on a smartphone or other portable device. The data will be transmitted and received from the device to and from the secure cloud using artificial intelligence AI. The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction. There is no guarantee that the device will be sold in the market on the date it will happen; all is subject to regulatory approvals. The early registrations are not binding and are made to create a waiting list, so there is no guarantee that the people that registered will order the device as there is no financial commitment from their side at this point. For Further Information, please refer to the information available on the Company's website: www. David Kugelman Toll Free - U. This press release includes certain statements that may be deemed 'forward-looking statements' within the meaning of Section 27A of the Securities Act of , as amended, and Section 21E of the Securities Exchange Act of , as amended. Those forward-looking statements include, without limitation, statements regarding the Company's expectations for the growth of the Company's operations and revenue. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the Company with the Canadian securities regulatory authorities, including without limitation in the Company's management's discussion and analysis for the year ended December 31, and annual information form dated March 31, , which are available under the Company's profile at www. Securities and Exchange Commission on April 27, Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements except as required by law. The Company has an effective shelf registration statement as of June and is intending to raise funds in the very near future. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward-looking statements. Selected edition. Sign in. My Portfolio News Latest News. Stocks: Most Actives. Credit Cards. Latest News. Tue, Nov 7, , PM 8 min read. Story Continues. Privacy Policy.

Yahoo Finance

Ashkelon buying Cannabis

Israeli medical cannabis company Together TASE: TGDR has announced that it has signed a Memorandum of Understanding MoU to market and distribute medical cannabis products in the Brazilian market, through a partner who will be responsible for receiving the required approvals to import medical cannabis products for sale in the country. The company plans to focus on selling enriched CBD oils for treating epilepsy. Together CEO Nissim Bracha said, 'The Brazilian market is an enormous market with a population that is 20 times larger than Israel so that we see major economic potential in Brazil to generate revenue from medical cannabis oils, while expanding our international presence. We are currently completing the construction of a factory for manufacturing medical cannabis products in Ashkelon next to the farm. We will allocate a special area for producing GMP products, adapted to the regulation required in Brazil, which permits imports but does not allow local cultivation, thus opening up a big business opportunity for us. Brazil has approved the setting up of the medical cannabis sector as part of which patients can buy cannabis products in pharmacies, and for the first time use cannabis legally with a medical prescription. However, the proposal to also build cultivation and production facilities in the country has been rejected, so that most of the cannabis is imported from abroad, without importing the plants' ingredients, only as a finished product or raw material from source. The company estimates that developing the medical cannabis sector in Brazil can make Brazil into the world's largest market for importing cannabis. The sector is working on a 'pilot' format for three years, after which the situation will be reviewed. Marketing of cannabis-based cosmetics and food products will not be allowed. Brazil has a population of more than million. In the case of Brazil, it can be assumed that within two years there will be two million medical cannabis users. There are 1. Published by Globes, Israel business news - en. Israeli medical cannabis co Together signs Brazilian deal Together greenhouses. Globes correspondent. Together has signed a distribution deal for marketing CBD oils for treating epilepsy. Together wins medical cannabis export permit from Uganda. Ralco to invest NIS 20m in cannabis co Together. Together forms JV to enter China's medical cannabis market. Together greenhouses. Together Pharma raises NIS

Ashkelon buying Cannabis